Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

Autor: Francesco Cerisoli, Farzad Ali, Tamás Bereczky, Natacha Bolaños, Lars Bullinger, Sujith Dhanasiri, James Gallagher, Sonia García Pérez, Jan Geissler, Yann Guillevic, Kathryn Harrison, Anastasia Naoum, Carla Portulano, Ana E. Rodríguez Vicente, Renate Schulze-Rath, Gabriela Yumi Gómez, Guillermo Sanz, Jesús María Hernández Rivas

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Value in Health

OBJECTIVES: The Innovative Medicines Initiative-funded, multistakeholders project Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in hematologY (HARMONY) created a task force involving patient organizations, medical associati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92fe9270fefc7a49f6fbebef635948a
https://doi.org/10.1016/j.jval.2022.04.1729

Health-Related Quality of Life (HRQoL) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Who Are Triple-Class Exposed to an Immunomodulatory Agent, a Proteasome Inhibitor, and an Anti-CD38 Antibody

Autor: Nina Shah, Ravi Vij, Jenna S. Roberts, Ivana Rajkovic, Rebecca Silbermann, Jens Hillengass, Sujith Dhanasiri, Julia Braverman, Abigail McMillan, Devender Dhanda

Publikováno v: Blood. 140:13259-13261

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::81637b236347a09eee286db47805f7c3
https://doi.org/10.1182/blood-2022-158235

Safety and Survival Outcomes in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-Based or Non-Lenalidomide-Based Treatments in the Real-World MM-034 Study

Autor: Michele Cavo, Sujith Dhanasiri, Valerio De Stefano, Angel Ramírez Payer, Martin Wiesholzer, Yvonne Tromp, Meegahage Ratnakanthi Perera, Valentine Richez-Olivier, Maciej Gil, David Bernasconi, Barbara Gamberi

Publikováno v: Blood. 140:7195-7196

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::16e027a8a0495518721a9dd79600075f
https://doi.org/10.1182/blood-2022-162493

Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy

Autor: Simon Walker, David E C Alderson, Vijay K. D'Souza, Jayne Galinsky, Vanessa Buchanan, Sujith Dhanasiri, Graham Jackson

Publikováno v: European Journal of Haematology

Objective This study examined productivity losses in European patients with newly diagnosed multiple myeloma (NDMM) undergoing autologous stem cell transplantation (ASCT), to better understand and model the impact of NDMM and lenalidomide maintenance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9902aa744ffec7d0d5d7cc47f9e18102
https://doi.org/10.1111/ejh.13298

P-195: Lenalidomide, bortezomib, and dexamethasone (RVd) as first-line (1L) therapy in patients who are non-transplanted: results from the Connect® MM registry

Autor: Rafat Abonour, Hans Lee, Robert Rifkin, Sikander Ailawadhi, James Omel, James Hardin, Brian Durie, Mohit Narang, Kathleen Toomey, Cristina Gasparetto, Lynne Wagner, Howard Terebelo, Jorge Mouro, Sujith Dhanasiri, Liang Liu, Edward Yu, Sundar Jagannath

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 22:S142

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df81cdf697350c207d5bd9ba489c99c9
https://doi.org/10.1016/s2152-2650(22)00525-0